Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DISCOVERY PARTNERS INTERNATIONAL INC | 7,643,800 | reported | 15 Nov 2018 | tx 12+2,415,932 |
| Merus N.V. | 2,588,511 | reported | 21 Jan 2021 | tx 3+844,680 |
| PALVELLA THERAPEUTICS, INC. | 2,385,055 | reported | 06 Sept 2019 | tx 3−50,000 |
| XOMA Royalty Corp | 1,750,704 | reported | 23 Sept 2020 | tx 6+51,368 |
| IDEAYA Biosciences, Inc. | 1,204,052 | reported | 22 Jun 2020 | tx 6+117,996 |
| Xenon Pharmaceuticals Inc. | 1,056,928 | reported | 27 Jun 2017 | tx 3+85,461 |
| Nivalis Therapeutics, Inc. | 717,089 | reported | 20 Jun 2017 | tx 9+90,456 |
| Rain Therapeutics Inc. | 555,105 | reported | 13 May 2021 | tx 3+58,000 |
| FIVE PRIME THERAPEUTICS INC | 536,608 | reported | 20 Dec 2019 | tx 3+515,020 |
| Olema Pharmaceuticals, Inc. | 336,288 | reported | 10 Jan 2025 | tx 7+519,556−420,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jan 2025 | OTHER | Olema Pharmaceuticals, Inc. | 161,810 | — | |
| 10 Jan 2025 | OTHER | Olema Pharmaceuticals, Inc. | 235,450 | — | |
| 10 Jan 2025 | OTHER | Olema Pharmaceuticals, Inc. | 22,740 | — | |
| 10 Jan 2025 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 161,810 | — | deriv |
| 10 Jan 2025 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 235,450 | — | deriv |
| 10 Jan 2025 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 22,740 | — | deriv |
| 31 Mar 2021 | OTHER | Olema Pharmaceuticals, Inc. | 99,556 | — | |
| 13 May 2021 | PURCHASE | Rain Therapeutics Inc. | 31,805 | 14.26 USD | |
| 13 May 2021 | PURCHASE | Rain Therapeutics Inc. | 3,474 | 14.26 USD | |
| 13 May 2021 | PURCHASE | Rain Therapeutics Inc. | 22,721 | 14.26 USD | |
| 10 Mar 2021 | GRANT_AWARD | CELL THERAPEUTICS INC | 80,000 | 0.00 USD | deriv |
| 21 Jan 2021 | PURCHASE | Merus N.V. | 43,422 | 24.75 USD | |
| 21 Jan 2021 | PURCHASE | Merus N.V. | 343,444 | 24.75 USD | |
| 21 Jan 2021 | PURCHASE | Merus N.V. | 457,814 | 24.75 USD | |
| 23 Sept 2020 | PURCHASE | XOMA Royalty Corp | 9,888 | 18.20 USD | |
| 21 Sept 2020 | PURCHASE | XOMA Royalty Corp | 10,069 | 18.39 USD | |
| 22 Sept 2020 | PURCHASE | XOMA Royalty Corp | 6,960 | 18.45 USD | |
| 23 Sept 2020 | PURCHASE | XOMA Royalty Corp | 7,201 | 18.20 USD | |
| 21 Sept 2020 | PURCHASE | XOMA Royalty Corp | 12,259 | 18.39 USD | |
| 22 Sept 2020 | PURCHASE | XOMA Royalty Corp | 4,991 | 18.45 USD | |
| 22 Jun 2020 | PURCHASE | IDEAYA Biosciences, Inc. | 7,854 | 13.93 USD | |
| 22 Jun 2020 | PURCHASE | IDEAYA Biosciences, Inc. | 1,354 | 13.93 USD | |
| 22 Jun 2020 | PURCHASE | IDEAYA Biosciences, Inc. | 10,524 | 13.93 USD | |
| 19 Jun 2020 | PURCHASE | IDEAYA Biosciences, Inc. | 6,769 | 14.39 USD | |
| 19 Jun 2020 | PURCHASE | IDEAYA Biosciences, Inc. | 39,052 | 14.39 USD |
1 purchase reported after at least 12 months of silence — most recent on 20 Dec 2019.